title: Antiretroviral treatments' durability and costs: important elements in the choice of first-line therapy.
authors: aCentre for Research on Health Economics, Social and Healthcare Management (CREMS), LIUC - Università Cattaneo, Castellanza, Italy bSchool of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa cFirst and Second Divisions of Infectious Diseases, 'Luigi Sacco' Hospital, Milan, Italy dSchool of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
authors: Umberto
authors: U
authors: Restelli
authors: Davide
authors: D
authors: Croce
authors: Giuliano
authors: G
authors: Rizzardini
mesh_terms: D019380:Anti-HIV Agents / Q000191:economics / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000191:economics*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans
chemical_list: D019380:Anti-HIV Agents